These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3963919)

  • 1. Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution.
    Stone JJ; Piccione W; Berrizbeitia LD; Dance GR; Schoen FJ; Shemin RJ; Cohn LH
    Ann Thorac Surg; 1986 Apr; 41(4):419-24. PubMed ID: 3963919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
    Engelman RM; Rousou JH; Dobbs WA
    Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics.
    Rude RE; Bush LR; Tilton GD
    Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.
    Mustafa I; Leverve XM
    Shock; 2002 Oct; 18(4):306-10. PubMed ID: 12392272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Breyer RH; Allred C; Forouhar F
    Int J Artif Organs; 1985 Sep; 8(5):281-6. PubMed ID: 3936789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits.
    Beisbarth H; Madjidi A; Frey R
    Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart.
    Ueda K; Genda T; Hirata I; Shimada M; Shibata T; Ueda T; Omoto R
    J Heart Lung Transplant; 1992; 11(4 Pt 1):646-55. PubMed ID: 1498127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term morphologic and hemodynamic evaluation of the left ventricle after cardiopulmonary bypass. A comparison of normothermic anoxic arrest, coronary artery perfusion, and profound topical cardiac hypothermia.
    Brody WR; Reitz BA; Andrews MJ; Roberts WC; Michaelis LL
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):1073-87. PubMed ID: 1186284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.
    Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Holman WL
    ASAIO J; 1995; 41(3):M636-41. PubMed ID: 8573883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
    Gartman DM; McDonagh PF; Geha AS
    Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
    [No Abstract]   [Full Text] [Related]  

  • 18. A hyperosmolar-colloidal additive to the CPB-priming solution reduces fluid load and fluid extravasation during tepid CPB.
    Kvalheim V; Farstad M; Haugen O; Brekke H; Mongstad A; Nygreen E; Husby P
    Perfusion; 2008 Jan; 23(1):57-63. PubMed ID: 18788219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass.
    Holman WL; Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Pacifico AD
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):774-85. PubMed ID: 7564446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.